RG
Redmile Group’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Sell |
3,732,888
-319,039
| -8% | -$3.63M | 4.53% | 7 |
|
|
2025
Q1 | $48.1M | Sell |
4,051,927
-140,700
| -3% | -$1.67M | 4.55% | 5 |
|
|
2024
Q4 | $79M | Sell |
4,192,627
-88,354
| -2% | -$1.66M | 5.51% | 3 |
|
|
2024
Q3 | $96.2M | Sell |
4,280,981
-142,635
| -3% | -$3.21M | 5.67% | 2 |
|
|
2024
Q2 | $92.3M | Sell |
4,423,616
-59,400
| -1% | -$1.24M | 5.58% | 3 |
|
|
2024
Q1 | $65.9M | Buy |
4,483,016
+1,226,497
| +38% | +$18M | 2.42% | 12 |
|
|
2023
Q4 | $33.6M | Buy |
3,256,519
+407,692
| +14% | +$4.21M | 1.2% | 25 |
|
|
2023
Q3 | $22.4M | Sell |
2,848,827
-8,482
| -0.3% | -$66.7K | 1.07% | 30 |
|
|
2023
Q2 | $28.5M | Buy |
2,857,309
+107,925
| +4% | +$1.08M | 1.1% | 28 |
|
|
2023
Q1 | $24.4M | Sell |
2,749,384
-251,400
| -8% | -$2.23M | 1.06% | 38 |
|
|
2022
Q4 | $32.9M | Sell |
3,000,784
-5,900
| -0.2% | -$64.8K | 1.35% | 24 |
|
|
2022
Q3 | $39.2M | Hold |
3,006,684
| – | – | 1.52% | 21 |
|
|
2022
Q2 | $38.1M | Sell |
3,006,684
-12,100
| -0.4% | -$153K | 1.45% | 23 |
|
|
2022
Q1 | $42.3M | Buy |
3,018,784
+60,500
| +2% | +$848K | 1.32% | 21 |
|
|
2021
Q4 | $85.6M | Sell |
2,958,284
-134,793
| -4% | -$3.9M | 1.95% | 14 |
|
|
2021
Q3 | $92.7M | Sell |
3,093,077
-97,000
| -3% | -$2.91M | 1.62% | 22 |
|
|
2021
Q2 | $84.6M | Sell |
3,190,077
-124,040
| -4% | -$3.29M | 1.25% | 26 |
|
|
2021
Q1 | $103M | Buy |
3,314,117
+467,992
| +16% | +$14.5M | 1.45% | 20 |
|
|
2020
Q4 | $93.6M | Buy |
2,846,125
+252,555
| +10% | +$8.3M | 1.13% | 27 |
|
|
2020
Q3 | $90.5M | Buy |
+2,593,570
| New | +$90.5M | 1.66% | 15 |
|